MariMed Inc., a leading multi-state cannabis operator and public equity company, has recently announced the completion of its acquisition of Kind Therapeutics USA LLC, a licensed Maryland medical cannabis dispensary. This marks MariMed’s second dispensary in Maryland, as they continue to expand their presence in the state’s rapidly growing medical cannabis market.
Kind Therapeutics is located in Hyattsville, Maryland, and has been serving the community with high-quality medical cannabis products since 2018. With this acquisition, MariMed now has two dispensaries in the state, further strengthening their position as a leading provider of medical cannabis products in Maryland.
Bob Fireman, CEO of MariMed, expressed excitement about the acquisition, stating that Kind Therapeutics has built a strong reputation for providing patients with top-notch medical cannabis products and services. He added that MariMed is committed to upholding the high standards set by Kind Therapeutics and continuing to serve patients with the best possible care.
Maryland’s medical cannabis market has been rapidly expanding, with more patients turning to cannabis as a safe and effective treatment option for various medical conditions. With the addition of Kind Therapeutics to their portfolio, MariMed is well-positioned to capitalize on this growing demand and provide patients with access to high-quality medical cannabis products.
Overall, MariMed’s acquisition of Kind Therapeutics is a strategic move that further solidifies their position in the Maryland medical cannabis market. As they continue to expand their presence in the state and provide patients with top-notch products and services, MariMed is well-positioned for continued growth and success in the evolving cannabis industry.
Source
Photo credit www.cannabisbusinesstimes.com
